Delivery Order SPE2DB20D3303-SPE2DB25FZ4V9

Award Date 4/3/25
Potential Completion Date 4/24/25
Potential Value $4.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,542.74 Firm Fixed Price Delivery Order is for the supply of YONSA 125 MG TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of March 25, 2025 and was awarded on March 4, 2025. This award is associated with AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,390.96 Firm Fixed Price Delivery Order contract is for the supply of YONSA 125 MG TABLET 120S, a medical product, with an ultimate completion date of December 10, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,195.48 firm fixed-price delivery order is for the supply of YONSA 125 MG TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of November 6, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $2,195.48 and covers the delivery of YONSA 125 MG TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of December 10, 2024 and is a Firm Fixed Price Delivery Order. This award is not associated with a specific set-aside designation....
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,542.74, is for the delivery of 4567908489 YONSA 125 MG TABLET 120S. The contract is a Firm Fixed Price Delivery Order with a completion date of May 5, 2025. The contract was awarded on April 14, 2025 and does not have a set-aside designation. Amerisourcebergen Drug Corp holds a $999,999,999...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,908,460 units of the drug YONSA 125 MG TABLET 120S, with a ceiling value of $2,271.36. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of May 5, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,271.36 firm fixed-price delivery order is for the supply of 4,568,141,590 units of the pharmaceutical product YONSA 125 MG TABLET 120S. The contract has an ultimate completion date of May 27, 2025. This award is not designated as a set-aside and was competed openly. AmerisourceBergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,390.98 firm fixed price delivery order is for the supply of 4557877684 YONSA 125 MG TABLET 120S, with a performance period through August 12, 2022. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, is for the delivery of 4,565,585,290 units of the drug YONSA 125 MG TABLET 120S. The $2,195.48 firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency, on August 26, 2024, with a completion date of September 17, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of YONSA 125 MG TABLET 120S. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $2,195.48. It does not have a set-aside designation. Amerisourcebergen, through its Corporate Office Division, will supply the specified medication to support military treatment facilities and other federal healthcare providers....
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB25FZ4V9
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is a Delivery Order valued at $4,542.74 with a firm fixed price and an ultimate completion date of April 24, 2025.

The contract is for the supply of YONSA 125 MG TABLET 120S, a pharmaceutical product. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

This contract award does not have a set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor, and there is no information provided about any subcontractors.

Generated 7/3/25, 3:10 PM